In the past, when patients needed imaging, such as an MRI, the test was done and diagnosis performed within a hospital. The expensive overhead associated with hospital-based radiology, however, makes the industry ripe for disruption and one small company, RadNet (NASDAQ: RDNT) is taking advantage of that opportunity. It already operates over 300 freestanding offices, but it’s also winning business by teaming up with hospital systems, providing them with on-demand staffing or off-site diagnosis, and technology tools that allow them to easily share imaging in the cloud.
In this clip from The Motley Fool’s Industry Focus: Healthcare, host Shannon Jones and Motley Fool contributor Todd Campbell consider if RadNet is a stock worth buying.
Inside The Motley Fool: Check out our Culture Blog!
Join our Facebook community:
Follow The Motley Fool on Twitter: